Search - tctmd.com

Displaying 681 - 700 of 2313

Sort: Relevancy | Date

Presentation TCT 2019

Race-Based Differences in Hypertension Management: What’s Relevant?

Presenter: Clyde Yancy

September 28, 2019

Presentation TCT 2019

Sex-Based Differences in Hypertension Management: Do They Exist?

Presenter: Ileana Pina

September 28, 2019

Presentation TCT 2019

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

Presenter: Michael Weber

September 28, 2019

Presentation TCT 2019

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Clinical Context of SOLO and Future Results and Implications for Who to Treat

Presenter: Naomi Fisher

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Presenter: Chandan Devireddy

September 27, 2019

Presentation TCT 2019

Introduction to Session

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Treating Patients With Renal Insufficiency: Zero Contrast PCI

Presenter: Ziad Ali

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation TCT 2019

The Target BP Program: Ongoing and Future Studies

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: How is it Different?

Presenter: Melvin Lobo

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presentation TCT 2019

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presenter: David Israeli

September 26, 2019

Presentation TCT 2019

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

Presenter: Andrew Sharp

September 25, 2019

$TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up$

Presentation TCT 2019

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

Presenter: Daniil Maximkin

September 25, 2019

Presentation TCT 2019

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

Presenter: Byeong-Keuk Kim

September 25, 2019

Advertisement

Race-Based Differences in Hypertension Management: What’s Relevant?

Sex-Based Differences in Hypertension Management: Do They Exist?

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Clinical Context of SOLO and Future Results and Implications for Who to Treat

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Introduction to Session

Treating Patients With Renal Insufficiency: Zero Contrast PCI

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

The Target BP Program: Ongoing and Future Studies

Clinical Evaluation: Peregrine Results to Date

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Alcohol-Mediated Renal Denervation: How is it Different?

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content